Why ESG

ESG HUB > News >
16 Dec
WHAT-ARE-THE-ESG-MATERIALITY-ISSUES-IN-THE-PHARMACEUTICAL-SECTOR-IN-SWITZERLAND
What are the ESG materiality issues in the pharmaceutical sector in Switzerland?
Category: Blog
“The pharmaceutical sector in Switzerland is a major industry, accounting for approximately 7% of GDP, and 35% of manufacturing.” The Swiss pharma business is the largest pharma bu...
13 Dec
Who are ESG investors?
Who are ESG investors?
Category: Blog
Environmental, social, and governance (ESG) funds are becoming increasingly popular worldwide. Institutional investors and shareholders are increasingly looking for impact investme...
14 Nov
Why do pre-IPO companies need to invest in ESG?
Why do pre-IPO companies need to invest in ESG?
Category: Blog
“Environmental, social and governance (ESG) strategy is quickly moving from a ‘good’ to a ‘must-have’ strategy for pre-IPO companies preparing to enter the market.” In recent years...